Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Scilex Holding Co (SCLX)

  • Technical Exchange News
  • Nov. 09, 2024, 03:32 UTC
  • 44
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Precigen Inc (PGEN)

  • Technical Exchange News
  • Nov. 09, 2024, 03:31 UTC
  • 44
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • Nov. 09, 2024, 03:30 UTC
  • 44
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • Nov. 09, 2024, 03:30 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Biodexa Pharmaceuticals PLC (BDRX)

  • Technical Exchange News
  • Nov. 09, 2024, 03:30 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Adaptimmune Therapeutics plc (ADAP)

  • Technical Exchange News
  • Nov. 09, 2024, 03:30 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Scilex Holding Co (SCLX)

  • Technical Exchange News
  • Nov. 08, 2024, 19:30 UTC
  • 42
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Precigen Inc (PGEN)

  • Technical Exchange News
  • Nov. 08, 2024, 19:29 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • Nov. 08, 2024, 19:27 UTC
  • 40
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • Nov. 08, 2024, 19:27 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text
  • Previous
  • 318
  • 319
  • 320
  • 321
  • 322
  • Next

Search

News categories

  • Technical Exchange News(10898)
  • Event(2315)
  • SEC News(190439)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124846)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin